The financial terms of an ATryn partnership in the US will undoubtedly be much better than the terms GTC got from Leo because ATryn is now an approved drug and GTC’s bargaining position is considerably stronger.
“The efficient-market hypothesis may be the foremost piece of B.S. ever promulgated in any area of human knowledge!”